Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanosphere Verisens(TM) Ultra-Sensitive PSA Assay Combined With the AnalizaDx SIA Technology Shows Promising Results for Improved Prostate Cancer Diagnosis

Abstract:
At the annual meeting of the North-Central American Urological Association, Mark Stovsky, MD, Case Western Reserve University School of Medicine -- Case Medical Center, and principal investigator, presented positive data combining the AnalizaDx SIA technology with the Nanosphere Verisens(TM) ultra-sensitive PSA assay (research use only). Nanosphere is collaborating with AnalizaDx -- which has developed a proprietary platform to screen for protein biomarkers in serum and other biological fluids -- on development of next-generation PSA tests for prostate cancer.

Nanosphere Verisens(TM) Ultra-Sensitive PSA Assay Combined With the AnalizaDx SIA Technology Shows Promising Results for Improved Prostate Cancer Diagnosis

Northbrook, IL | Posted on October 7th, 2010

Data presented for blood serum showed that at a sensitivity of 100%, the specificity was 76%, with a negative predictive value of 100% (ruling out patients who do not have prostate cancer) and a positive predictive value of 84% (likelihood that a patient ruled in would have cancer based on biopsy). The use of the Nanosphere Verisens(TM) ultra-sensitive PSA assay achieved sensitivity and specificity required for prostate cancer diagnosis, that is not possible with existing commercial assays.

In addition to Case Western, the academic investigators were from Cleveland Clinic, the Veterans Administration Healthcare System in Boston, and the National Cancer Institute.

About Verisens(TM) PSA (RUO)

Verisens(TM) PSA is an in-vitro diagnostic assay for the high-sensitivity detection and quantification of prostate specific antigen (PSA). The assay was developed in collaboration with the International Institute for Nanotechnology at Northwestern University. Currently, it is intended to be performed as a testing service for research use only (see research-use notification below).

About SIA

Solvent Interaction Technology (SIA) is a highly promising technology with the potential to discover and screen for structural changes in circulating proteins in serum and other biological fluids. SIA assay chemistries can be developed directly from actual clinical samples, and without requiring a priori structural or mechanistic assumptions. Furthermore, the technology is highly automatable, and once validated, could be readily transferred to the clinic.

For additional information regarding the PSA assay, please contact Nanosphere at

Nanosphere is also engaged in other cancer research and validation for protein biomarkers, independently and with commercial collaborations.

For additional information regarding the cancer protein biomarkers and commercial collaborations, please contact Nanosphere at

RESEARCH USE NOTIFICATION

Nanosphere, Inc. is required by the U.S. Food and Drug Administration (FDA) to certify in writing that its customers, who purchase or who are supplied with products labeled "For Research Use Only," acknowledge and understand that such products are not for use in diagnostic or therapeutic procedures. Tests performed with in vitro products intended for "Research Use Only" are tests used in a preclinical or nonclinical setting. While research tests may be performed using either clinical or nonclinical materials, research use devices have no intended clinical use and the testing performed is not designed to provide data addressing or demonstrating safety and effectiveness. We advise our customers to monitor the use of these products, to ensure that they are used for research purposes only. Please contact Nanosphere if you have questions.

####

About Nanosphere
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene(R) system, for ultra-sensitive protein, human genetic and infectious disease detection. This easy to use and cost effective platform enables simple, low cost and highly sensitive testing on a single platform.

Nanosphere is based in Northbrook, IL.

For more information, please click here

Contacts:
Nanosphere, Inc.
Winton Gibbons, SVP, Business Development
(847) 400-9029


ANALIZA, Inc.
Arnon Chait, Ph.D., President and CEO
216.432.9050 x118


The Torrenzano Group
Media and Investors:
212-681-1700

Copyright © Nanosphere

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Academic/Education

COD Grad Begins Postdoctoral Fellow at Harvard University: Marsela Jorgolli's Passion for Physics Has Led to a Decade of Academic Research That Continues at Harvard University as a Postdoctoral Fellow February 2nd, 2016

Heriot-Watt's Institute of Photonics & Quantum Sciences uses the Deben Microtest 2 kN tensile stage to characterise ceramics and engineering plastics January 21st, 2016

Multiple uses for the JPK NanoWizard AFM system in the Smart Interfaces in Environmental Nanotechnology Group at the University of Illinois at Urbana-Champaign January 20th, 2016

BioSolar Extends Research Agreement With UCSB for Next Phase of Its Super Battery Technology: Development Effort to Continue Under the Supervision of Nobel Laureate, Dr. Alan Heeger January 13th, 2016

Nanomedicine

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Nanoparticles Make Fertility Possible during Consumption of Anticancer Drugs February 4th, 2016

Announcements

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Nanobiotechnology

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Novel nanoparticle made of common mineral may help keep tumor growth at bay February 4th, 2016

Nanoparticles Make Fertility Possible during Consumption of Anticancer Drugs February 4th, 2016

Using mathematics to improve human health February 3rd, 2016

Alliances/Trade associations/Partnerships/Distributorships

Vesper Collaborates with GLOBALFOUNDRIES to Deliver First Piezoelectric MEMS Microphones: Acoustic sensing company works with top foundry to support mass-market consumer products January 21st, 2016

Imec and Cloudtag Collaborate on High Quality Frictionless Wearables for Lifestyle Coaching: Next-generation health and fitness tracker Cloudtag TrackTM launched at CES 2016 January 7th, 2016

Technical partnership at the top Oxford Instruments and Zurich Instruments announce a technical collaboration for low temperature physics January 7th, 2016

Production of Graphene Oxide Nanosheets to Economize Fuel Cells January 1st, 2016

Research partnerships

Polar vortices observed in ferroelectric: New state of matter holds promise for ultracompact data storage and processing February 4th, 2016

Spin dynamics in an atomically thin semi-conductor February 1st, 2016

Graphene shown to safely interact with neurons in the brain January 31st, 2016

Are some people more likely to develop adverse reactions to nanoparticle-based medicines? January 31st, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic